On the segmental front, the company’s revenue from the sugar business stood at Rs 1,103.22 crore (down 14.98% YoY), distillery came in at Rs 289.05 crore (down 0.17% YoY), consumer products stood at Rs 143.03 crore (down 39.46%), crop protection was at Rs 1,098.29 crore (up 72.78% YoY), and nutrient and allied business was at Rs 7,761.77 crore (up 21.9% YoY) during the period under review.

On the other hand, the firm’s income from nutraceuticals was at Rs 61.91 crore (up 44.25% YoY), and revenue from cogeneration stood at Rs 36.59 crore (down 10.36% YoY) in Q3 FY26.

Segment-wise, the farm inputs division continued to lead performance, recording a profit before interest and tax (PBIT) of Rs 741 crore for the quarter, up 3.35% from Rs 717 crore a year ago. Consolidated sugar operations, including refinery business, reported a loss before interest and tax of Rs 30 crore for the quarter ended 31st December 2025 as compared to a loss of Rs 59 crore in the corresponding quarter of the previous year.

The consolidated nutraceuticals division reported a loss before interest and tax of Rs 2 crore for the quarter ended 31st December 2025 as compared to Rs 5 crore in the corresponding quarter of the previous year.

EID Parry (India) is engaged in sugar, nutraceuticals, and ethanol production. It also has a significant presence in the farm inputs business, including biopesticides, through its subsidiary, Coromandel International.

Shares of EID Parry (India) rose 0.95% to Rs 990.45 on the BSE.